Zurich WM reshuffles team as CEO steps back
Sloan Asset Management's Oliver Baumann is stepping back from his role as CEO, shifting instead to a position on the board of directors, Citywire Switzerland can reveal. Baumann will primarily be focusing on his new position as CEO of XLife Sciences, a firm centred around founding and supporting medical technology…
Continue Reading
Subscribe to unlock the full article and access premium financial content.
Click here to read the full story: Citywire

